Upgrading mass spectrometry for better proteomics analysis at Georgia Tech
Bruker timsTOF HT Mass Spectrometer to Support Proteomics Research in the Georgia Tech Core Facilities
This study is all about getting a new, high-tech machine at Georgia Tech that will help scientists study proteins more accurately and efficiently, which will benefit various health research projects.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Institute of Technology NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11102381 on NIH RePORTER |
What this research studies
This project aims to enhance proteomics research capabilities at Georgia Tech by acquiring a state-of-the-art Bruker timsTOF HT mass spectrometer. This new instrument will replace outdated technology, allowing for more accurate and efficient analysis of proteins. The upgrade will support various NIH-funded projects and improve the quality of research conducted in the Systems Mass Spectrometry Core facility. By integrating advanced ion mobility spectrometry with mass spectrometry, the new system promises to deliver significant improvements in sensitivity and specificity for proteomics studies.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals involved in NIH-funded proteomics studies, particularly those focused on understanding complex diseases at the molecular level.
Not a fit: Patients who are not involved in research studies or those whose conditions are not being investigated through proteomics may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise and reliable proteomics data, ultimately benefiting patients through improved understanding of diseases and better-targeted therapies.
How similar studies have performed: Previous research has shown success with similar mass spectrometry upgrades, indicating that this approach is backed by evidence of improved performance in proteomics analysis.
Where this research is happening
Atlanta, United States
- Georgia Institute of Technology — Atlanta, United States (Active)
Researchers
- Principal investigator: Torres, Matt Phillip — Georgia Institute of Technology
- Study coordinator: Torres, Matt Phillip
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.